TrialNaunyn-Schmiedeberg's archives of pharmacology2025

The pharmacokinetics, pharmacodynamics and tolerability of SHR6508 in chinese healthy subjects: a randomized, placebo-controlled, double-blind, single-dose and dose-escalation phase I trial.

Sheng-Ting Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.